Pro Share Advisors LLC Humanigen, Inc Transaction History

Pro Share Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$1.81 - $3.97 $19,298 - $42,328	-10,662 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$3.66 - $8.22 $39,022 - $87,641	10,662 New	10,662 $40,000
Q3 2021 Nov 12, 2021	SELL	$5.93 - $17.83 $69,001 - $207,469	-11,636 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$13.54 - $22.74 $157,551 - $264,602	11,636 New	11,636 $202,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.